Cleared Traditional

K941014 - ENA SCREEN ELISA TEST SYSTEM

K941014 is an FDA 510(k) clearance for ENA SCREEN ELISA TEST SYSTEM, manufactured by Zeus Scientific, Inc.. The device is a Class 2 Immunology device with product code LJM cleared through the Traditional 510(k) pathway after a 99-day FDA review.

K941014 · Zeus Scientific, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1994
Decision
99d
Days
Class 2
Risk

K941014 is an FDA 510(k) clearance for the ENA SCREEN ELISA TEST SYSTEM. Classified as Antinuclear Antibody (enzyme-labeled), Antigen, Controls (product code LJM), Class II - Special Controls.

Submitted by Zeus Scientific, Inc. (Raritan, US). The FDA issued a Cleared decision on June 10, 1994 after a review of 99 days - within the typical 510(k) review window.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Zeus Scientific, Inc. devices

FDA 510(k) Submission Details - K941014

510(k) Number K941014 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 03, 1994
Decision Date June 10, 1994
Days to Decision 99 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
5d faster than avg
Panel avg: 104d · This submission: 99d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJM Device Classification - Class 2, Special Controls

Product Code LJM Antinuclear Antibody (enzyme-labeled), Antigen, Controls
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - LJM Antinuclear Antibody (enzyme-labeled), Antigen, Controls

All 50
Devices cleared under the same product code (LJM) and FDA review panel - the closest regulatory comparables to K941014.
VARELISA SCL-70 ANTIBODIES
K944172 · Elias U.S.A., Inc. · Dec 1994
VARELISA JO-1 ANTIBODIES
K944173 · Elias U.S.A., Inc. · Dec 1994
RADIAS ANA SCREEN ENZYME IMMUNOASSAY
K941509 · Bio-Rad · Jun 1994
ENA PROFILE-6 ELISA TEST SYSTEM
K941409 · Zeus Scientific, Inc. · Jun 1994
SYNELISA ANA TOTAL
K935468 · Elias U.S.A., Inc. · Mar 1994
ELIAS ANA TOTAL
K940641 · Elias U.S.A., Inc. · Mar 1994